An official website of the United States government
September 29, 2026 Edition
News
Antiviral drug did not improve Long COVID symptoms
A clinical trial for Long COVID found that treating patients with a common antiviral drug for up to 25 days did not improve symptoms.
News
tRNA treatment may help restore cystic fibrosis proteins
Lipid nanoparticles delivering engineered transfer RNA restored functional proteins in cell and animal models of cystic fibrosis.
News
Bacterial infection may alter developing gut
C. difficile bacteria caused lasting changes to cells in the intestines of newborn mice.
Displaying 904 - 910 of 912
Monitoring bacteria in the body with ultrasound
Researchers engineered genes that allowed them to detect bacteria in the bodies of mice. The technique could allow tracking of bacteria used in treatments for gut infections and cancer.
Stem cell transplant helps people with severe scleroderma
A study of people with severe scleroderma found that a new approach using stem cell transplants provides a better outcome than an immune-suppressing drug.
Does infant formula affect development of type 1 diabetes?
Results from a new study suggest no change in current guidelines for formula feeding in infants who are at risk for type 1 diabetes.
Factors contributing to higher incidence of diabetes for black Americans
A study found that biological risk factors—including weight and fat around the abdomen—are primarily responsible for the elevated rate of diabetes for black Americans.
Air pollution linked to risk of premature death
A comprehensive analysis found that even short-term exposures to air pollution may have an impact on the health of older adults.
Technique treats hereditary deafness in mice
Researchers developed a genome editing strategy to treat hearing loss in a mouse model of hereditary deafness.
Research in Context
In-depth articles that focus on cutting-edge NIH biomedical research topics, describing the current state of research in a field and where it may be heading.